FDA Hopes Artificial Pancreas Guidance is Flexible, Encouraging

Devices & Diagnostics Letter
A A
The FDA intends a new draft guidance on development of artificial pancreas device systems to be a map rather than a roadblock, an FDA official said in a Dec. 1 briefing.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00